“Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial” (2023) Althea Medical Journal, 10(4), pp. 242–251. doi:10.15850/amj.v10n4.3279.